Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration
- 1 May 1992
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 102 (5) , 1760-1763
- https://doi.org/10.1016/0016-5085(92)91740-u
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Meta-analysis of value of propranolol in prevention of variceal haemorrhageThe Lancet, 1990
- Propranolol in Prevention of Rebleeding from Oesophageal Varices during the Course of Endoscopic SclerotherapyScandinavian Journal of Gastroenterology, 1989
- Variceal bleeding: acute and long-term managementBailliere's Clinical Gastroenterology, 1989
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesNew England Journal of Medicine, 1988
- Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliterationHepatology, 1986
- Improved Survival Following Injection Sclerotherapy for Esophageal Varices: Final Analysis of A Controlled TrialHepatology, 1985
- A Prospective, Randomized Controlled Trial of Chronic Esophageal Variceal SclerotherapyHepatology, 1985
- FAILURE OF REPEATED INJECTION SCLEROTHERAPY TO IMPROVE LONG-TERM SURVIVAL AFTER OESOPHAGEAL VARICEAL BLEEDINGThe Lancet, 1983
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981